TGFB1 and neoplasm: In OSCC, the application of miRNAs mimics targeting TGF-β1 effectively reduced the gene expression of TGF-β1, inhibited growth, invasion, and metastasis of tumor cells and increased the sensitivity of drug-resistant cells to cisplatin (42).